Back to the main directory
Company Analysis / Equity
- CARREFOUR: Not alarming, Kantar's market shares are rather reassuring as to the execution of the plan | BUY | EUR20(+21%) by Bryan Garnier
- GENMAB - BUY | DKK1450(+5%) Promising data for Enapotamab Vedotin in NSCLC and first-line Japan approval by Bryan Garnier
- IPSEN: Onyvide scores in 1L metastatic pancreatic cancer | BUY | EUR147(+21%) by Bryan Garnier
- JPJ Group plc - Pro forma figures; 10.5% EPS accretion in FY20 by Edison Investment Research
- Acarix - Patch reordering and an emerging US strategy by Edison Investment Research
- EQS Group - Emerging from investment phase by Edison Investment Research
- Findel - Outstanding value by Edison Investment Research
- Nabaltec - Margin expansion sustained by Edison Investment Research
- paragon - Growing pains at Voltabox by Edison Investment Research
- Artificial Solutions (ASAI.SE): 1Q’19 results – customer traction, numbers on track by Hardman & Co
- Palace Capital (PCA): Portfolio and trading update by Hardman & Co
- Titon Holdings (TON): You need hands by Hardman & Co
- Palace Capital (PCA): Conversion to REIT status; FY19 results announced by Hardman & Co
- Morses Club (MCL): Steady, reliable core, growth in new business lines by Hardman & Co
- QIWI - Positive Changes in Betting Regulation by Sberbank
- Russian Banks - CBR Plans Lower Corporate Loan Risk Weights by Sberbank
- Polymetal - Strong 2Q19 Trading Update, TP Raised on Positive Gold Outlook by Sberbank
- CIS Market Daily - July 31, 2019 by Sberbank
- Nornickel - Strong 2Q19 Production Results; Buy on Good Ni/Pd Price Outlook by Sberbank
- CIS Market Daily - August 26, 2019 by Sberbank
- Moscow Exchange - Solid Defensive Play, BUY Reiterated by Sberbank
- CIS Market Daily - 27 авгуÑта 2019 by Sberbank
- Polymetal - 1H19 IFRS In Line; BUY Reiterated by Sberbank
- NLMK - Weak 3Q19 Earnings, As Expected; Downgrade to HOLD by Sberbank
- HEINEKEN: Weak first half profit figures, downgrade to Neutral | NEUTRAL vs. BUY | EUR100(-2%) by Bryan Garnier